| Merck (Schweiz) AG - Luveris 75 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| 55430 | | 01 | | Luveris 75 IE | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | G03GA07 | | Lutropin alfa | | 27.09.2002 | | |
|
| Composition |
| Praeparatio cryodesiccata: lutropinum alfa 3.7 µg, saccharum, methioninum, polysorbatum 20, dinatrii phosphas dihydricus, natrii dihydrogenophosphas monohydricus, acidum phosphoricum q.s. ad pH, natrii hydroxidum q.s. ad pH, pro vitro corresp. natrium 0.219 mg.
Solvens: aqua ad iniectabile 1 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisat et solvant | | | | | | | | Principe actif | Concentr. |
|---|
| Lutropine Alfa | 3.7 µg |
| | BAG: Principe actif | Concentr. |
|---|
| Lutropinum Alfa | 3.7 mcg |
| | | | Agents auxilliaires |
|---|
| Acide Phosphorique | | Disodium Phosphate Dihydrate | | Methionine | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 20 | | Saccharum |
| |
| Solvens | | | aqua ad iniectabile 1 ml | | | | | | BAG: Principe actif | Concentr. |
|---|
| Lutropinum Alfa | 3.7 mcg |
|
| Solvens | | | aqua ad iniectabile 1 ml | | | | | | BAG: Principe actif | Concentr. |
|---|
| Lutropinum Alfa | 3.7 mcg |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 007 | Flacon perforable | 40.70 | 60.70 | A | LS | Non |
|
